Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)
Others
Ratios

Benitec Biopharma (BNTC) Shares Outstanding (Diluted Average) (2021 - 2025)

Benitec Biopharma's Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $38.6 million for Q1 2025.

  • For Q1 2025, Shares Outstanding (Diluted Average) rose 111.13% year-over-year to $38.6 million; the TTM value through Mar 2025 reached $38.6 million, up 111.13%, while the annual FY2024 figure was $18.4 million, 1225.17% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2025 was $38.6 million at Benitec Biopharma, up from $37.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $38.6 million in Q1 2025 and bottomed at $480688.0 in Q2 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $6.2 million (2021), against an average of $11.2 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) tumbled 92.19% in 2022 before it surged 1346.03% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $8.2 million in 2021, then tumbled by 86.17% to $1.1 million in 2022, then surged by 128.01% to $2.6 million in 2023, then soared by 1346.03% to $37.3 million in 2024, then rose by 3.61% to $38.6 million in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Shares Outstanding (Diluted Average) are $38.6 million (Q1 2025), $37.3 million (Q4 2024), and $27.9 million (Q3 2024).